Cuba has two COVID-19 vaccine candidates in phase III of clinical trials after the regulatory authority on Thursday approved Abdala to pass to that stage.
We offer a summary of events in Cuba over the last 12 months, since the first cases of COVID-19 were confirmed on the island.
The Havana-based Immunoessay Research Center informed that Cuba has a new Ultra Micro Analytical System, which allows detecting several diseases early, among them Covid-19, local press reported on Thursday.
The Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH) in the province of Holguín, the only one of its kind in Cuba, prioritizes the follow-up programs for its patients, amid the epidemiological contingency generated by COVID -19, widespread on the Caribbean island.
Cubans who received Nasalferon drug in February (99.4 percent of 100,000) have shown optimal results to fight Covid-19.